22 July 2022
: Case report 
Multidrug-Resistant Klebsiella pneumoniae in a Patient with SARS-Cov-2 Pneumonia in an Intensive Care Unit in Guayaquil, Ecuador: A Case Report
Unusual clinical course
Betty J. Pazmiño Gómez1ACDE*, Jennifer P. Rodas Pazmiño
2BCDF, Gabriel S. González Quinde 2BCEF, Jorge F. Guevara Viejó 1BCF, Miguel J. Merejildo Amaguaña 3BDF, Édgar I. Rodas Neira 4CDEF, Francisco A. Rizzo Rodríguez 5BDF, Luis E. Cagua Montaño 1CDF, Karen A. Rodas Pazmiño 1BDF
DOI: 10.12659/AJCR.936498
Am J Case Rep 2022; 23:e936498
Table 3. Blood culture confirmation Klebsiella pneumoniae, NDM strain (confirmed at the INSPI Guayaquil, Ecuador). Microbiological findings.Klebsiella pneumoniae ss. Pneumonia.
| Cefotaxime | 6 mm | |
| Ciprofloxacin | 6 mm | |
| Meropenem | 12 mm | |
| Cefepime | 6 mm | |
| Ertapenem | 10 mm | |
| Colistin_MDC | ||
| Identification method | ||
| Sensitivity test | ||
| Interpretation rule | ||
| Carbapenemase | ||
| Inactivation Carbapenemes mCIM | ||
| Inactivation Carbapenemes eCIM | ||
| Synergy ABP-IMI | ||
| Synergy EDTA-IMI | ||
| Molecular biology research | ||
| bla-KPC | ||
| bla-VIM | ||
| bla-IMP | ||
| bla-NDM | ||
| bla-OXA48 | ||
| Comments | ||
| Ceftazidime | 6 mm | |
| Gentamicin | 20 mm | |
| Imipenem | 10 mm | |
| Amikacin | 19 mm | |
| Aztreonam | 12 mm | |
| 0.5 ug/Ml (I) | ||
| Manual | ||
| CIM-BMD + DD | ||
| CLSI | ||
| Positive | ||
| Positive | ||
| Positive | ||
| Negative | ||
| Positive | ||
| Yes | ||
| Negative | ||
| Negative | ||
| Negative | ||
| Positive | ||
| Negative | ||
| NDM-type carbapenemase-producing microorganism Consider use of combination therapy Please maintain vigilance of the microorganism | ||
| Antimicrobial susceptibility interpretation of blood culture confirmed at the INSPI. | ||